Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa

Alshreef, A, MacQuilkan, K, Dawkins, B orcid.org/0000-0002-7038-1975 et al. (9 more authors) (2019) Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa. Value in Health Regional Issues, 19. pp. 65-74. ISSN 2212-1099

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 ISPOR--The professional society for health economics and outcomes research. Published by Elsevier Inc. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Transferability; model adaptation; low- and middle-income countries; early breast cancer
Dates:
  • Published: September 2019
  • Published (online): 13 May 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Health Economics (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 23 May 2019 10:40
Last Modified: 23 May 2019 10:40
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.vhri.2019.03.001

Share / Export

Statistics